CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Endpoints News
Original article

Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal

PartnershipPositive
AI Analysis

Summary

Alnylam Pharmaceuticals announced a collaboration with AI startup Inceptive, paying $30M upfront as part of its first discovery-focused AI deal to enhance RNA R&D capabilities.

Importance:6/10
Sentiment:
0.60
partnershipAIR&Ddrug discoveryRNA
Related Companies

Read the original article

Published by Endpoints News on June 3, 2026 8:45 PM

Read Original